Fort Point Capital Partners LLC Avidity Biosciences, Inc. Transaction History
Fort Point Capital Partners LLC
- $794 Million
- Q3 2025
A detailed history of Fort Point Capital Partners LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 31,278 shares of RNA stock, worth $2.21 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
31,278
Previous 31,095
0.59%
Holding current value
$2.21 Million
Previous $883,000
54.25%
% of portfolio
0.17%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
312Shares Held
139MCall Options Held
1.24MPut Options Held
531K-
Janus Henderson Group PLC London, X014.5MShares$1.03 Billion0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$936 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY11.4MShares$805 Million6.62% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$713 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.79MShares$693 Million0.05% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $3.69B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...